How To Show The US FDA You’ll Be Marketing The Same Cell And Gene Therapies You Trialed

With characterization of cell and gene therapies still in its infancy, the FDA shares advice on how to demonstrate comparability between the versions manufactured for clinical trials and the versions to be produced for commercial use. Starting earlier with scalable manufacturing processes helps. Limited additional clinical studies may be needed in some cases.